Paper41007256
Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy.
Rajneesh and 10 others. Biology (Basel), 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy. Papers, record 41007256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007256
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Institute of Eminence Grant | Banaras Hindu University, Varanasi | PubMed |
Source PubMed
References194
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24498219 | Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients. | PLoS One | 2014 | https://conductscience.org/library/papers/24498219 | PubMed |
| 2 | 10551740 | PCNA/AgNOR and Ki-67/AgNOR double staining in oral squamous cell carcinoma. | J Oral Pathol Med | 1999 | https://conductscience.org/library/papers/10551740 | PubMed |
| 3 | 34502102 | Hypoxia Pathway Proteins and Their Impact on the Blood Vasculature. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502102 | PubMed |
| 4 | 35116996 | TNF-α promotes tumor lymph angiogenesis in head and neck squamous cell carcinoma through regulation of ERK3. | Transl Cancer Res | 2019 | https://conductscience.org/library/papers/35116996 | PubMed |
| 5 | 16730260 | Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. | Adv Immunol | 2006 | https://conductscience.org/library/papers/16730260 | PubMed |
| 6 | 24702237 | Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. | Antioxid Redox Signal | 2014 | https://conductscience.org/library/papers/24702237 | PubMed |
| 7 | 2488320 | Clinical/technical challenges in adoptive cellular immunotherapy (ACI): the role of cytapheresis. | Immunol Ser | 1989 | https://conductscience.org/library/papers/2488320 | PubMed |
| 8 | 25962348 | Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study. | Pathol Oncol Res | 2015 | https://conductscience.org/library/papers/25962348 | PubMed |
| 9 | 36007522 | Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. | Cell Metab | 2022 | https://conductscience.org/library/papers/36007522 | PubMed |
| 10 | 31750584 | Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis. | Head Neck | 2020 | https://conductscience.org/library/papers/31750584 | PubMed |
| 11 | 38398094 | Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38398094 | PubMed |
| 12 | 33211709 | Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival. | PLoS One | 2020 | https://conductscience.org/library/papers/33211709 | PubMed |
| 13 | 31735641 | Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor. | Mol Cell | 2020 | https://conductscience.org/library/papers/31735641 | PubMed |
| 14 | 37099710 | Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A Systematic Review and Meta-analysis. | Med Oral Patol Oral Cir Bucal | 2023 | https://conductscience.org/library/papers/37099710 | PubMed |
| 15 | 27160553 | Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2. | Sci Rep | 2016 | https://conductscience.org/library/papers/27160553 | PubMed |
| 16 | 28397778 | Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer. | Diagnostics (Basel) | 2017 | https://conductscience.org/library/papers/28397778 | PubMed |
| 17 | 37038210 | The relationship between sphingosine-1-phosphate receptor 2 and epidermal growth factor in migration and invasion of oral squamous cell carcinoma. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/37038210 | PubMed |
| 18 | 25480554 | Chemokines in cancer. | Cancer Immunol Res | 2014 | https://conductscience.org/library/papers/25480554 | PubMed |
| 19 | 34414241 | lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-κB Signaling. | J Immunol Res | 2021 | https://conductscience.org/library/papers/34414241 | PubMed |
| 20 | 25818339 | Immune evasion in cancer: Mechanistic basis and therapeutic strategies. | Semin Cancer Biol | 2015 | https://conductscience.org/library/papers/25818339 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42812354 | Editorial: Integrative OMICS approaches in cancer biology: from molecular mechanisms to precision medicine. | Front Oncol | 2026 | https://conductscience.org/library/papers/42812354 | PubMed |
| 42516741 | Unraveling role of arginine-NO metabolism by targeting HIF-1α signaling in mediating esophageal squamous cell carcinoma. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42516741 | PubMed |
| 42371183 | Targeting metabolic reprogramming in HPV-associated oral squamous cell carcinoma: current advances, challenges, and clinical prospects. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42371183 | PubMed |
| 41374963 | Targeted Therapies in Oral and Oropharyngeal Cancer: An Overview of Emerging and Repurposed Agents. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41374963 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007256
GET https://conductscience.org/api/papers/v1/41007256/references?page=2